NCT06547710Recruiting
Primary Tumor Resection for M1a Stage Lung Cancer
Primary Tumor Resection for M1a Stage Lung Cancer With Occult Pleural Dissemination Discovered During Surgery: a Prospective, Single-arm, Multi-center, Phase Ⅱ Trial
Source: ClinicalTrials.gov · Last updated 8 Jul 2026
Brief summary (registry, in English)
This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1023. This study aims to explore the safety and efficacy of primary lesion resection in the treatment of M1a stage lung cancer with pleural dissemination found during surgery, and to more accurately evaluate whether primary lesion resection can improve the OS and quality of life of the corresponding patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 66 (estimated)
- First submitted
- 7 Aug 2024
- Start date
- 1 Apr 2024
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Fudan University
- Diseases
- Lung cancer
- NCT number
- NCT06547710
What you commit to
- Study type: Observational
- Planned participants: 66
- From 1 Apr 2024 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have received radiotherapy or chemotherapy and are not treatment-naive patients.
Other illness
- Cytological or histological pathology confirms other lung malignancies other than lung cancer;
- Patients who have undergone lung cancer surgery before;
Other
- The lesion cannot be completely removed surgically;
Who the study is looking for
- Volunteer to participate in clinical research, willing to follow and able to complete all trial procedures;
- Aged 18-80 years (including critical values) when signing the informed consent form;
- ECOG score 0 or 1;
- No previous lung cancer surgery;
- Intraoperative or postoperative pathological confirmation of M1a stage lung cancer;
- Occult pleural metastasis found during surgery;
- First-time treatment and no radiotherapy or chemotherapy.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fudan University Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.